Smith Hayes Advisers’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$3.17M Sell
30,545
-772
-2% -$75.1K 0.64% 43
2015
Q4
$3.06M Sell
31,317
-5,272
-14% -$516K 0.65% 43
2015
Q3
$3.53M Sell
36,589
-123
-0.3% -$12.9K 0.76% 36
2015
Q2
$3.85M Buy
36,712
+531
+1% +$54.3K 0.76% 32
2015
Q1
$3.73M Sell
36,181
-3,558
-9% -$360K 0.74% 33
2014
Q4
$3.83M Sell
39,739
-691
-2% -$60.9K 0.8% 28
2014
Q3
$3.22M Buy
40,430
+4,882
+14% +$385K 0.75% 34
2014
Q2
$2.68M Sell
35,548
-131
-0.4% -$9.9K 0.63% 51
2014
Q1
$2.67M Sell
35,679
-467
-1% -$33K 0.66% 47
2013
Q4
$2.59M Buy
36,146
+348
+1% +$22.4K 0.85% 34
2013
Q3
$2.03M Sell
35,798
-1,793
-5% -$107K 0.78% 39
2013
Q2
$2.15M Buy
+37,591
New +$2.18M 0.89% 32

Other funds holding CVS

Smith Hayes Advisers's CVS Position: Q1 2016 in Review

Smith Hayes Advisers reduced its CVS Health (CVS) stake by 2.5% in Q1 2016, selling an estimated $75.1K and leaving 30,545 shares worth $3.17M. The position accounts for 0.64% of the portfolio, ranked #43.

Smith Hayes Advisers first reported a position in CVS in Q2 2013 and has held it in 12 quarters since. The position peaked at $3.85M in Q2 2015. 1,562 funds tracked by Wall St. Rank hold CVS as of Q1 2016.

  • Smith Hayes Advisers held 30,545 shares of CVS Health worth $3.17M as of Q1 2016.
  • Smith Hayes Advisers sold 772 CVS Health shares in Q1 2016, an estimated $75.1K.
  • CVS Health made up 0.64% of Smith Hayes Advisers's portfolio in Q1 2016, its #43 holding.
  • Smith Hayes Advisers first reported a position in CVS Health in Q2 2013 and has held it in 12 quarters since.
  • Smith Hayes Advisers's CVS Health position peaked at $3.85M in Q2 2015.
  • 1,562 funds tracked by Wall St. Rank held CVS Health as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.